US Patent Issued to The Regents of the University of California on Feb. 3 for "Nano-enabled immunotherapy in cancer" (California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,338, issued on Feb. 3, was assigned to The Regents of the University of California (Oakland, Calif.).

"Nano-enabled immunotherapy in cancer" was invented by Andre E. Nel (Sherman Oaks, Calif.), Huan Meng (Los Angeles) and Kuo-Ching Mei (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "In certain embodiments a platform technology for the facilitating immune therapy in the treatment of cancer is provided. In certain embodiments nanocarriers are provided that facilitate delivery of an IDO inhibitor in conjunction with an inducer of cell death (ICD-inducer). In certain embodiments the IDO inhibitor is conjugated to a component of a lipid bilaye...